Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population-based sample in Uganda

Journal of Infectious Diseases

Volumn 202, Issue 9, 2010, Pages 1347-1353

  Biryahwaho, Benon ^a   Dollard, Sheila C ^b   Pfeiffer, Ruth M ^c   Shebl, Fatma M ^c   Munuo, Stella ^d   Amin, Minal M ^b   Hladik, Wolfgang ^b   Parsons, Ruth ^d   Mbulaiteye, Sam M ^c  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; DEMOGRAPHY; ENVIRONMENTAL FACTOR; ENZYME IMMUNOASSAY; FEMALE; GEOGRAPHY; HEALTH SURVEY; HERPES VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION RISK; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; POPULATION; PRIORITY JOURNAL; RHADINOVIRUS; RISK FACTOR; SEX; UGANDA; VIRUS GENE; VIRUS INFECTION; BLOOD; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; SARCOMA, KAPOSI; SEX RATIO; YOUNG ADULT;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; GEOGRAPHY; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; UGANDA; YOUNG ADULT;

EID: 77958113195     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/656525     Document Type: Article

References (34)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
2. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003; 88:1-3. (Pubitemid 36241209)
3. Cook-Mozaffari P, Newton R, Beral V, Burkitt DP. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 1998; 78:1521-1528. (Pubitemid 28517552)
4. Ziegler JL. Endemic Kaposi's sarcoma in Africa and local volcanic soils. Lancet 1993; 342:1348-1351.
5. Whitby D, Marshall VA, Bagni RK, et al. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Int J Cancer 2007; 120:321-328. (Pubitemid 44956841)
6. Coluzzi M, Calabro ML, Manno D, Chieco-Bianchi L, Schulz TF, Ascoli V. Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites. J Infect Dis 2004; 190:199-200; author reply, 200-201. (Pubitemid 38858422)
7. Engels EA, Sinclair MD, Biggar RJ, et al. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta. Int J Cancer 2000; 88:1003-1008.
8. Ariyoshi K, Schim van der Loeff M, Cook P, et al. Kaposi's sarcoma in the Gambia,West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998;1:193-199. (Pubitemid 128543034)
9. Taylor JF, Smith PG, Bull D, Pike MC. Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 1972; 26:483-497.
10. Bunnell R, Opio A, Musinguzi J, et al. HIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative survey. AIDS 2008; 22:617-624. (Pubitemid 351640594)
11. Mermin J, Musinguzi J, Opio A, et al. Risk factors for recent HIV infection in Uganda. JAMA 2008; 300:540-549.
12. 2002 Uganda Population and Housing Census. Kampala: Government of Uganda (Uganda Bureau of Statistics), 2007.
13. Pau CP, Lam LL, Spira TJ, et al. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998; 36:1574-1577.
14. Spira TJ, Lam L, Dollard SC, et al. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000; 38:2174-2180. (Pubitemid 30414334)
15. Rao JNK, Scott AJ. The analysis of categorical data from complex surveys: chi-squared test for goodness of fit and independence in two-way tables. J Am Stat Assoc 1981; 76:221-230.
16. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000; 82:1585-1592.
17. Bestetti G, Renon G, Mauclere P, et al. High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 1998; 12:541-543. (Pubitemid 28116172)
18. Hladik W, Dollard SC, Downing RG, et al. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J Acquir Immune Defic Syndr 2003; 33:206-210. (Pubitemid 36793157)
19. Baeten JM, Chohan BH, Lavreys L, et al. Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya. AIDS 2002; 16:2073-2078. (Pubitemid 35205272)
20. Wawer MJ, Eng SM, Serwadda D, et al. Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda. Sex Transm Dis 2001; 28:77-81. (Pubitemid 32151902)
21. Malope BI, MacPhail P, Mbisa G, et al. No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 2008; 22:519-526. (Pubitemid 351317294)
22. Sitas F, Carrara H, Beral V, et al. Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med 1999; 340:1863-1871. (Pubitemid 29272666)
23. Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ. Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily. Ann Epidemiol 2009; 19:597-601.
24. Mbulaiteye SM, Pfeiffer RM, Whitby D, Brubaker GR, Shao J, Biggar RJ. Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003; 187:1780-1785. (Pubitemid 36667889)
25. Brooker S, Kabatereine NB, Smith JL, et al. An updated atlas of human helminth infections: the example of East Africa. Int J Health Geogr 2009; 8:42.
26. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003; 3:733-744. (Pubitemid 41070814)
27. Lin CJ, Katongole-Mbidde E, Byekwaso T, Orem J, Rabkin CS, Mbulaiteye SM. Intestinal parasites in Kaposi sarcoma patients in Uganda: indication of shared risk factors or etiologic association. Am J Trop Med Hyg 2008; 78:409-412. (Pubitemid 351845190)
28. Williams EH, Williams PH. A note on an apparent similarity in distribution of onchocerciasis, femoral hernia and Kaposi's sarcoma in the West Nile district of Uganda. East Afr Med J 1966; 43:208-209.
29. Mbulaiteye SM, Pfeiffer RM, Dolan B, et al. Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis 2008; 14:586-591.
30. Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12:1921-1925.
31. Mbulaiteye SM, Goedert JJ. Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa. AIDS 2008; 22:535-537.
32. Mbulaiteye SM, Pfeiffer RM, Engels EA, et al. Detection of Kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004; 190:1382-1386.
33. Mbulaiteye S, Marshall V, Bagni RK, et al. Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 2006; 193:1250-1257.
34. Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis 1998; 178:304-309.